Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model

This study confirms the effectiveness of R18 in reducing the severity of ischemic brain injury and improving functional outcomes after stroke in a NHP model, and provides further support for its clinic al development as a stroke neuroprotective therapeutic.

http://link.springer.com/10.1007/s13311-019-00809-1

Source: Neurotherapeutics - December 11, 2019 Category: Neurology Source Type: research